Delivery Order SPE2D021DA002-SPE2D325F257F
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 by the Defense Logistics Agency's Medical Supply Chain division for TWINRIX vaccine syringes. The award, issued on July 21, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $8,014.60. The award, which has no set-aside designation, was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. It covers the supply of Twinrix vaccine syringes, with a period of performance through August 6, 2024. DMS Pharmaceutical Group holds a significant...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $95,392.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the TWINRIX VACCINE SYRINGE, with a completion date of June 14, 2024. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX VACCINE SYRINGE and has a completion date of June 21, 2024. DMS Pharmaceutical Group Inc. holds a separate, larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,808.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX VACCINE SYRINGE and has an ultimate completion date of August 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business organization based in Park Ridge, Illinois. The $1,602.92 contract is for the delivery of the TWINRIX VACCINE SYRINGE with a completion date of February 7, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, SPE2DB, with the Defense Logistics Agency valued up to $4,999,999 through 2025 to provide a...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Twinrix vaccine syringes. The award, valued at $8,395.56, has a completion date of May 17, 2022 and does not have a set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drugs to the federal government, particularly...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the Twinrix vaccine syringe. The $2,347.29 contract has an August 23, 2023 completion date and was awarded on August 22, 2023. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products in support of...
- This is a federal contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $4,007.30 fixed-price delivery order contract was issued by the Defense Logistics Agency (DLA) on March 13, 2024 and has an ultimate completion date of March 14, 2024. The contract is for the delivery of TWINRIX vaccine syringes to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery...
- The Defense Logistics Agency awarded a $7,041.87 firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business. This order is for the Twinrix vaccine syringe, a medical product, and has an expected completion date of April 28, 2023. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic pharmaceutical and medical supplies to the Department of Defense under various contracts and indefinite delivery...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F257FDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,636.62 on July 24, 2025, for the supply of Twinrix vaccine syringes. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, was issued without a set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The award represents a continuation of DMS Pharmaceutical Group's ongoing role as a critical supplier within the federal pharmaceutical distribution network. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. Under this comprehensive vehicle, the company supplies a broad portfolio of pharmaceutical products, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The Twinrix vaccine delivery exemplifies the company's core business of distributing vaccines and immunological products to support military health system requirements, leveraging its established position as a trusted federal pharmaceutical supplier since its registration in the System for Award Management in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/24/25 |